Everest Organics share news, announcements and annual reports
BSE: 524790Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹241.50.
30 Oct: open ₹243.95, high ₹248.90, low ₹231.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹234 Cr2,120th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.49
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.10
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.66
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 177
Everest Organics share news and announcements
621 announcements, routine notices left out, newest first. Page 2 of 13.
Apr 2025
4 Apr · Announcement under Regulation 30 (LODR)-Change in Corporate Office Address
Mar 2025
Feb 2025
18 Feb · Intimation Of Korea Drug Master File (KDMF) Approval For Company'S Rabeprazole Sodium API
13 Feb · Meeting
11 Feb · Results
5 Feb · Board meeting
Meeting on 11 Feb 2025: quarterly results
Jan 2025
13 Jan · Meeting
13 Jan · Management
13 Jan · Announcement under Regulation 30 (LODR)-Allotment
13 Jan · Board meeting
9 Jan · Board meeting
Meeting on 13 Jan 20258 Jan · Meeting
Dec 2024
13 Dec · Business
12 Dec · Board meeting
9 Dec · Board meeting
Meeting on 12 Dec 2024: preferential issue of shares9 Dec · Board meeting
Nov 2024
13 Nov · Management
13 Nov · Management
13 Nov · Results
13 Nov · Results
8 Nov · Board meeting
Meeting on 13 Nov 2024: quarterly results
Oct 2024
4 Oct · Announcement under Regulation 30 (LODR)-Retirement
Sep 2024
28 Sep · Meeting
27 Sep · Meeting
9 Sep · Announcement under Regulation 30 (LODR)-Demise
6 Sep · Corporate action